In mouse models of RA, administration of neutralizing anti-IL-10 antibodies showed an acceleration of arthritis [61], while intraarticular overexpression of IL-10 diminished synovitis and cartilage proteoglycan depletion [62]. This evidence concerns the gene IL10 and rheumatoid arthritis.